The incremental cost of non-alcoholic steatohepatitis and type 2 diabetes in the United States using real-world data

Both NASH and T2D contribute to the high healthcare costs among patients with a dual diagnosis. Results from our analysis indicate that NASH comprises a high portion of total healthcare costs among patients with NASH and T2D.